TNF and Alzheimer disease: Generally, several studies indicate that blocking the TNF-α pathway in AD models is associated with: (I) improvement in memory decline, as tested in different behavioral tests evaluating cognitive function; (II) reduction in immunohistochemical and histopathological markers like formation of Aβ plaques and NFT; and (III) reduction in the number of microglial cells in the AD brain (139).